R. Crevel, B. K. Ballmer-weber, S. L. Taylor, G. Houben, and C. Mills, Chapter five -428 Thresholds or 'How Much Is Too Much?, Madsen CB, Crevel RWR

S. L. Taylor and . Eds, Risk Management for Food Allergy, vol.430, pp.77-99, 2014.

R. Crevel, D. Briggs, S. L. Hefle, A. C. Knulst, and S. L. Taylor, Hazard characterisation in 432 food allergen risk assessment: The application of statistical approaches and the use of 433 clinical data, Food and Chemical Toxicology, vol.45, pp.691-701, 2007.

S. L. Taylor, S. L. Hefle, C. Bindslev-jensen, S. A. Bock, A. W. Burks et al., , p.435

A. Host, J. O. Hourihane, G. Lack, D. D. Metcalfe, D. A. Moneret-vautrin et al., Factors affecting the determination 437 of threshold doses for allergenic foods: how much is too much?, J Allergy Clin Immunol, vol.438, pp.24-30, 2002.

M. Spanjersberg, A. G. Kruizinga, M. Rennen, and G. F. Houben, Risk assessment and food 440 allergy: the probabilistic model applied to allergens, Food and Chemical Toxicology, vol.441, pp.49-54, 2007.

C. B. Madsen, S. Hattersley, J. Buck, S. M. Gendel, G. F. Houben et al., , p.443

E. N. Mills, P. Norhede, S. L. Taylor, and R. W. Crevel, Approaches to risk assessment in food 444 allergy: report from a workshop ''developing a framework for assessing the risk from 445 allergenic foods, Food Chem Toxicol, vol.47, pp.480-489, 2009.

L. Rimbaud, F. Heraud, L. Vieille, S. Leblanc, J. Crepet et al., , p.447

, Assessment Relating to Adventitious Presence of Allergens in Food: A Probabilistic 448 Model Applied to Peanut in Chocolate, Risk Analysis, vol.30, pp.7-19, 2010.

R. Crevel, J. L. Baumert, S. Luccioli, A. Baka, S. Hattersley et al., Translating reference doses into allergen 451 management practice: Challenges for stakeholders, Food and Chemical Toxicology, vol.452, pp.277-87, 2014.

S. L. Taylor, J. L. Baumert, and A. G. Kruizinga, , p.454

S. , A. Kj, and G. Houben, Establishment of Reference Doses for residues of allergenic 455 foods: Report of the VITAL Expert Panel, Food and Chemical Toxicology, vol.63, pp.9-456, 2014.

K. Blumchen, A. Beder, J. Beschorner, F. Ahrens, A. Gruebl et al., , p.458

A. Heinzmann, K. Nemat, B. Niggemann, U. Wahn, and K. Beyer, Modified oral food 459 challenge used with sensitization biomarkers provides more real-life clinical thresholds 460 for peanut allergy, Journal of Allergy and Clinical Immunology, vol.461, p.10, 2014.

A. Boulay, J. Houghton, V. Gancheva, Y. Sterk, A. Strada et al.,

R. Sala, R. Van-ree, and G. Rowe, A EuroPrevall review of factors affecting incidence of 463 peanut allergy: priorities for research and policy, Allergy, vol.63, p.11, 2008.

R. Crevel, J. L. Baumert, A. Baka, G. F. Houben, A. C. Knulst et al., , p.465

S. L. Taylor and C. B. Madsen, Development and evolution of risk assessment for food 466 allergens, Food and Chemical Toxicology, vol.67, p.12, 2014.

J. Hourihane, K. E. Grimshaw, S. A. Lewis, R. A. Briggs, J. B. Trewin et al., Does severity of low-dose, double-blind, placebo-controlled food 469 challenges reflect severity of allergic reactions to peanut in the community?, Clin Exp, vol.470, pp.1227-1260, 2005.

J. Hourihane, A. Knulst, T. Van-der-zee, A. Dubois, M. Kerkhof et al., The eliciting 474 dose of peanut in double-blind, placebo-controlled food challenges decreases with 475 increasing age and specific IgE level in children and young adults, Toxicology and 472 Applied Pharmacology, vol.207, p.15, 2005.

A. Crépet, A. Papadopoulos, C. F. Elegbede, C. Loynet, S. Ait-dahmane et al., MIRABEL: an integrated 479 project for risk and cost/benefit analysis of peanut allergy. Regulatory Toxicology and 480, Pharmacology, vol.71, p.16, 2015.

L. Guenard-bilbault, D. A. Moneret-vautrin, A. Papadopoulos, P. Beaumont, and C. Menetrey, , p.482

E. Beaudouin, J. Gayraud, M. Drouet, B. Sansas, and A. Crepet, Allergie à l'arachide en 483 France : premiers résultats de l'étude pilote du programme MIRABEL : « Approche 484 intégrée pour l'évaluation du risque et des coûts/bénéfices liés aux allergènes 485 alimentaires ». Revue Française d, Allergologie, vol.52, p.17, 2012.

A. Deschildre, C. F. Elegbede, J. Just, O. Bruyère, X. Van-der-brempt et al., , p.487

E. Beaudouin, J. Renaudin, A. Crépet, and D. Moneret-vautrin, Peanut allergic patients 488 in the MIRABEL survey: comorbidities and specificities of eliciting dose in real-life, Clinical and experimental allergy, vol.489, p.18, 2016.

J. Just, C. F. Elegbede, A. Deschildre, J. Bousquet, D. Moneret-vautrin et al., study-491 group M, Two severe peanut-allergy phenotypes with gender difference: Evidence from 492 the MIRABEL survey, Clinical and Experimental Allergy, vol.46, p.19, 2016.

C. Santos, A. Deschildre, E. Paty, L. Couderc, C. Marguet et al., Oral food challenge 494 in children: who, when, and how? Procedures Revue Française d'Allergologie et 495 d, Immunologie Clinique, vol.46, pp.659-69, 2006.

J. L. Fauquert, A. Deschildre, D. Sabouraud, and F. Rancé, Oral food challenge in children: 497 who, when, and how? Interpretation. Revue Française d'Allergologie et d'Immunologie 498, Clinique, vol.46, pp.470-74, 2006.

J. Hosmer, W. David, S. Lemeshow, and S. May, Applied Survival Analysis: Regression 500 Modeling of Time to Event Data, vol.501, p.22, 2008.

D. R. Cox, Regression Models and Life Tables (with Discussion), Journal of the Royal 502 Statistical Society, Series B, vol.34, p.23, 1972.

D. Lunn, D. Spiegelhalter, A. Thomas, and N. Best, The BUGS project: Evolution, critique 504 and future directions, Statistics in Medicine, vol.28, p.24, 2009.

A. F. Santos, D. Toit, G. Douiri, A. Radulovic, S. Stephens et al., Distinct 506 parameters of the basophil activation test reflect the severity and threshold of allergic 507 reactions to peanut, Journal of Allergy and Clinical Immunology, vol.135, p.25, 2015.

T. Reier-nilsen, M. M. Michelsen, L. Carlsen, K. C. Carlsen, K. H. Mowinckel et al., , p.509

U. C. Nygaard, E. Namork, M. P. Borres, and G. Håland, Predicting reactivity threshold in 510 children with anaphylaxis to peanut, Clinical & Experimental Allergy, vol.512, p.26, 2017.

V. L. Mcwilliam, J. J. Koplin, M. J. Field, M. Sasaki, S. C. Dharmage et al., , p.513

R. L. Peters and K. J. Allen, Self-reported adverse food reactions and anaphylaxis in the 514 SchoolNuts study: A population-based study of adolescents, Clinical Immunology, vol.141, p.27, 2018.

F. Codreanu, O. Collignon, O. Roitel, B. Thouvenot, C. Sauvage et al., , p.517

A. Decoster, J. M. Renaudin, C. Astier, J. M. Monnez, P. Vallois et al., , p.518

D. A. Vautrin, M. Brulliard, V. Ogier, M. C. Castelain, G. Kanny et al., A 519 Novel Immunoassay Using Recombinant Allergens Simplifies Peanut Allergy, p.520

, Diagnosis. International Archives of Allergy and Immunology, vol.154, pp.216-242, 2011.